Minaris Advanced Therapies
Pharmaceutical Manufacturing
400 Rouse Blvd, Philadelphia, United States
501-1000 Employees (View 696 on Prospeo)
Company overview
| Headquarters | 400 Rouse Blvd, Philadelphia, Pennsylvania 19112, US |
| Website | |
| NAICS | 3254 |
| Keywords | Product, Gene Therapy, Assay Development, Cell Therapy, Regenerative Medicine, Cgmp/Gtp Cryostorage, Cgmp Process, Gtp Cell And Tissue Processing And Sourcing, Cgmp Commercial Manufacturing, Viral Vector Product |
| Founded | 2025 |
| Employees | 501-1000 |
| Socials |
Minaris Advanced Therapies Email Formats
Minaris Advanced Therapies uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@minaris.com), used 85.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@minaris.com | 85.2% |
{first initial}.{last name} | j.doe@minaris.com | 14.4% |
About Minaris Advanced Therapies
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 650,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 25 years’ experience as a cell therapy CDMO and more than 40 years of expereince as a testing provider, we are a trusted partner for scalability, high quality results, and cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.
Minaris Advanced Therapies revenue & valuation
| Annual revenue | $37,500,000 |
| Revenue per employee | $45,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $120,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 501-1000
Employees by Department
Minaris Advanced Therapies has 382 employees across 14 departments.
Departments
Number of employees
Funding Data
Minaris Advanced Therapies has never raised funding before.
Minaris Advanced Therapies Tech Stack
Discover the technologies and tools that power Minaris Advanced Therapies's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
JavaScript libraries
Tag managers
CMS
Miscellaneous
Security
Miscellaneous
Font scripts
A/B Testing
Marketing automation
JavaScript libraries
France
Saudi Arabia
Spain
United Kingdom
Frequently asked questions
Key Contact at Minaris Advanced Therapies
4.8
40,000 users
